Skip to content

Interdisciplinary Rehabilitation of Patients With Chronic Widespread Pain

CompletedNot applicableNCT01352052
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The primary objective of the current study is to evaluate the outcome of an interdisciplinary multi-component rehabilitation programme customized to patients with chronic widespread pain (CWP) based on multidimensional diagnostic assessment including sub-grouping, and aiming to improve functional ability in everyday life. The hypothesis is that a patient-focused multi-disciplinary rehabilitation approach will improve both functional ability and quality of life for patients with CWP.

Study details

Official title
Interdisciplinary Rehabilitation and Evaluation Programme for Patients With Chronic Widespread Pain: Randomized Controlled Trial, the IMPROvE Study
Interventions
  • Other: interdisciplinary rehabilitation
Sponsor
Frederiksberg University Hospital
Collaborators
Oak Foundation
Start date
2011-05
Primary completion
2014-01
Sex
Female
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
Denmark
Total sites listed
2

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * age above 18 * fulfills the American College of Rheumatology (ACR) 1990 classification criteria of widespread musculoskeletal pain i.e. reporting of pain axially and in all 4 body quadrants for a minimum duration of 3 months * willing to participate in a 2-week group-based rehabilitation programme Exclusion Criteria: * severe physical impairment necessitating assistance in personal activities of daily living * concurrent history of major psychiatric disorder not related to the pain disorder * other medical conditions capable of causing patients symptoms (e.g. uncontrolled inflammatory/autoimmune disorder, uncontrolled endocrine disorder, malignancy) * not Danish speaking * enrollment in any other clinical trial within the last 30 days

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01352052